Related references
Note: Only part of the references are listed.Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
Semanti Mukherjee et al.
CANCER CELL (2022)
Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
Zhaowu Ma et al.
SEMINARS IN CANCER BIOLOGY (2022)
Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages
Pan Su et al.
CANCER RESEARCH (2020)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase
Erika M. Palmieri et al.
NATURE COMMUNICATIONS (2020)
Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21
Emer E. Hackett et al.
CELL REPORTS (2020)
RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis
Lei Wu et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Discovery and development of small molecule modulators targeting glutamine metabolism
Lei Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Saturated fatty acids induce NLRP3 activation in human macrophages through K+ efflux resulting from phospholipid saturation and Na, K-ATPase disruption
Marco A. Gianfrancesco et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma
Thomas J. Kaley et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group
Leo Mascarenhas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects
Shan-Ting Liao et al.
NATURE COMMUNICATIONS (2019)
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Gunnar Boysen et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase
Mario A. Lauterbach et al.
IMMUNITY (2019)
Malonylation of GAPDH is an inflammatory signal in macrophages
Silvia Galvan-Pena et al.
NATURE COMMUNICATIONS (2019)
Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma
Jennifer Wu et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2019)
Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis
Ajit S. Divakaruni et al.
CELL METABOLISM (2018)
PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolism
Victoria L. Nelson et al.
GENES & DEVELOPMENT (2018)
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Suzan J. G. Knottnerus et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression
Wei Xiang et al.
NATURE COMMUNICATIONS (2018)
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer The BOLERO-6 Randomized Clinical Trial
Guy Jerusalem et al.
JAMA ONCOLOGY (2018)
Glutaminase isoenzymes in the metabolic therapy of cancer
Jose M. Mates et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation
Feilong Wang et al.
CELL METABOLISM (2018)
Electrophilic properties of itaconate and derivatives regulate the I kappa B zeta-ATF3 inflammatory axis
Monika Bambouskova et al.
NATURE (2018)
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Evanna L. Mills et al.
NATURE (2018)
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Xiaoyue Zhao et al.
SCIENTIFIC REPORTS (2018)
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Yonggang Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis
Nicola Fazio et al.
CANCER SCIENCE (2018)
Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment
Di Liu et al.
JOURNAL OF PROTEOME RESEARCH (2017)
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Oren J. Becher et al.
PEDIATRIC BLOOD & CANCER (2017)
Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes
Ekta Lachmandas et al.
NATURE MICROBIOLOGY (2017)
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations
Kosei Hasegawa et al.
INVESTIGATIONAL NEW DRUGS (2017)
Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
Hui-Min Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Higher phagocytic activity of thioglycollate-elicited peritoneal macrophages is related to metabolic status of the cells
Sofia Pavlou et al.
JOURNAL OF INFLAMMATION-LONDON (2017)
Targeting tumor associated macrophages: The new challenge for nanomedicine
Fernando Torres Andon et al.
SEMINARS IN IMMUNOLOGY (2017)
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis
Erika M. Palmieri et al.
CELL REPORTS (2017)
2-Deoxy-d-glucose Treatment Decreases anti-inflammatory M2 Macrophage Polarization in Mice with Tumor and allergic airway inflammation
Qingjie Zhao et al.
FRONTIERS IN IMMUNOLOGY (2017)
Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
Susanne M. Steggerda et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Roles of PFKFB3 in cancer
Linlin Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan
Andrea J. Wolf et al.
CELL (2016)
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Mathias Wenes et al.
CELL METABOLISM (2016)
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
Vicky Lampropoulou et al.
CELL METABOLISM (2016)
Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity
Rob J. W. Arts et al.
CELL METABOLISM (2016)
Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation
Stanley Ching-Cheng Huang et al.
IMMUNITY (2016)
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis
Amanda Littlewood-Evans et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense
Hui Jiang et al.
JOURNAL OF IMMUNOLOGY (2016)
Fatty acid oxidation in macrophage polarization
Mitsunori Nomura et al.
NATURE IMMUNOLOGY (2016)
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
Jong-Seok Moon et al.
NATURE MEDICINE (2016)
Integrating immunometabolism and macrophage diversity
Maxim N. Artyomov et al.
SEMINARS IN IMMUNOLOGY (2016)
HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity
Hiroaki Semba et al.
NATURE COMMUNICATIONS (2016)
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
Min Xie et al.
NATURE COMMUNICATIONS (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages
Jan Van den Bossche et al.
CELL REPORTS (2016)
Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation
Anthony J. Covarrubias et al.
ELIFE (2016)
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages
Rob J. W. Arts et al.
ONCOIMMUNOLOGY (2016)
Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma
Hweixian Leong Penny et al.
ONCOIMMUNOLOGY (2016)
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
Wei Zhu et al.
PLOS ONE (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Macrophages: Development and Tissue Specialization
Chen Varol et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages
Judy Choi et al.
CANCER BIOLOGY & THERAPY (2015)
Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages
Eva M. Palsson-McDermott et al.
CELL METABOLISM (2015)
被撤回的出版物: UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis (Retracted article. See vol. 133, 2023)
Jong-Seok Moon et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Pyruvate Dehydrogenase Kinase 1 Participates in Macrophage Polarization via Regulating Glucose Metabolism
Zheng Tan et al.
JOURNAL OF IMMUNOLOGY (2015)
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Robert J. Motzer et al.
LANCET ONCOLOGY (2015)
Deregulation of PPARβ/δ target genes in tumor-associated macrophages by fatty acid ligands in the ovarian cancer microenvironment
Tim Schumann et al.
ONCOTARGET (2015)
Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment
Yang Zhao et al.
ONCOTARGET (2015)
mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Jong-Seok Moon et al.
CELL REPORTS (2015)
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Abhishek K. Jha et al.
IMMUNITY (2015)
A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation
Vittoria Infantino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization
Dmitry Namgaladze et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Dongsheng Zhang et al.
CANCER LETTERS (2014)
Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases
Anna Guidetti et al.
CLINICAL CANCER RESEARCH (2014)
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
E. M. Dunbar et al.
INVESTIGATIONAL NEW DRUGS (2014)
Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE
Alex J. Freemerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Edward T. Chouchani et al.
NATURE (2014)
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Stanley Ching-Cheng Huang et al.
NATURE IMMUNOLOGY (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
ATP-citrate lyase is essential for macrophage inflammatory response
Vittoria Infantino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
N. Colombo et al.
BRITISH JOURNAL OF CANCER (2013)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Regulation and function of pyruvate kinase M2 in cancer
Weiwei Yang et al.
CANCER LETTERS (2013)
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
Stephen Yiu Chuen Choi et al.
JOURNAL OF PATHOLOGY (2013)
Targeting 6-Phosphofructo-2-Kinase ( PFKFB3) as a Therapeutic Strategy against Cancer
Brian F. Clem et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
G. M. Tannahill et al.
NATURE (2013)
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Alessandro Michelucci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Two Phase 2 Trials of the Novel Akt Inhibitor Perifosine in Patients With Advanced Renal Cell Carcinoma After Progression on Vascular Endothelial Growth Factor-Targeted Therapy
Daniel C. Cho et al.
CANCER (2012)
Sustained Generation of Nitric Oxide and Control of Mycobacterial Infection Requires Argininosuccinate Synthase 1
Joseph E. Qualls et al.
CELL HOST & MICROBE (2012)
The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism
Arvand Haschemi et al.
CELL METABOLISM (2012)
Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas
Sant P. Chawla et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Mechanisms of triglyceride accumulation in activated macrophages
Kenneth R. Feingold et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
ACCELERATED PUBLICATION The mitochondrial citrate carrier: a new player in inflammation
Vittoria Infantino et al.
BIOCHEMICAL JOURNAL (2011)
Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1a
Seung-Soon Im et al.
CELL METABOLISM (2011)
Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J. Chen et al.
ONCOGENE (2011)
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
Ramon C. Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
Juan-Carlos Rodriguez-Prados et al.
JOURNAL OF IMMUNOLOGY (2010)
Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes
Josef Ecker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A. Rizzieri et al.
CLINICAL CANCER RESEARCH (2008)
Macrophage activation and polarization
Fernando Oneissi Martinez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
PX-478, an inhibitor of hypoxia-inducible factor-1α, enhances radiosensitivity of prostate carcinoma cells
Sanjeewani T. Palayoor et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1 alpha
Mei Y. Koh et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma
Howard H. Bailey et al.
CANCER (2006)
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Divya Vats et al.
CELL METABOLISM (2006)
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer
Athanassios Argiris et al.
CANCER BIOLOGY & THERAPY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Phase II study of perifosine in previously untreated patients with metastatic melanoma
DS Ernst et al.
INVESTIGATIONAL NEW DRUGS (2005)
GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo
WK Alderton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation
L Dugo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The mitochondrial transporter family (SLC25): physiological and pathological implications
F Palmieri
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
JE Wilson
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury
PK Chatterjee et al.
KIDNEY INTERNATIONAL (2003)
Species differences in macrophage NO production are important
M Schneemann et al.
NATURE IMMUNOLOGY (2002)
Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide
L Connelly et al.
JOURNAL OF IMMUNOLOGY (2001)
M-1/M-2 macrophages and the Th1/Th2 paradigm
CD Mills et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
